Literature DB >> 16131514

Public health response to urgent case reports.

David J Dausey1, Nicole Lurie, Alexis Diamond.   

Abstract

We evaluated the ability of local public health agencies (LPHAs) to meet a preparedness standard set by the U.S. Centers for Disease Control and Prevention (CDC): to receive and respond to urgent case reports of communicable diseases twenty-four hours a day, seven days a week. We found substantial variability in performance and in the systems in place to respond to such reports. Development and implementation of measures of public health agencies' performance are crucial to improving public health preparedness and, ultimately, to assuring the agencies.

Mesh:

Year:  2005        PMID: 16131514     DOI: 10.1377/hlthaff.w5.412

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  The global dimensions of public health preparedness and implications for US action.

Authors:  Melinda Moore
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Measuring the performance of telephone-based disease surveillance systems in local health departments.

Authors:  David J Dausey; Anita Chandra; Agnes G Schaefer; Ben Bahney; Amelia Haviland; Sarah Zakowski; Nicole Lurie
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

3.  Evidence links increases in public health spending to declines in preventable deaths.

Authors:  Glen P Mays; Sharla A Smith
Journal:  Health Aff (Millwood)       Date:  2011-07-21       Impact factor: 6.301

4.  Resilience to the health risks of extreme weather events in a changing climate in the United States.

Authors:  Kristie L Ebi
Journal:  Int J Environ Res Public Health       Date:  2011-12-08       Impact factor: 3.390

5.  Local public health workers' perceptions toward responding to an influenza pandemic.

Authors:  Ran D Balicer; Saad B Omer; Daniel J Barnett; George S Everly
Journal:  BMC Public Health       Date:  2006-04-18       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.